Valizadeh M, MD1,
Hamzehlo L, MD2, Mousavinasab N, PhD3, Amirmoghaddami HR,
DCLS4, Hayatbakhsh R, MD, PhD5
1- Associate
prof., Metabolic Diseases Research Center, Zanjan Faculty of Medicine, Zanjan
University of Medical Sciences, Zanjan, Iran. 2- Scientific Researcher, Health Centre
of Zanjan University of Medical Sciences, Zanjan Faculty of Medicine, Zanjan
University of Medical Sciences, Zanjan, Iran;. 3- Associate prof., Dept. of Social
Medicine, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan,
Iran. 4- Doctor of Clinical Laboratory Sciences, Dept. of Clinical Laboratory,
Vali E Asr General Hospital, Zanjan University of Medical Sciences, Zanjan,
Iran. 5- Senior Lecturer, School
of Population Health, University of Queensland, Herston Road, Herston 4006, Australia.
Background: There is no data available
regarding vitamin D status among patients with hip fractures in Iran. This
study aimed to determine whether postmenopausal women with low trauma hip
fractures have lower vitamin D levels comparing to the control group. Materials
and Methods: Vitamin D (25-OHD) level and the
prevalence of hypovitaminosis D among 73 postmenopausal women with fracture
of the hip (caused by low trauma) was compared to this level among 76
controls (patients with high energy traumatic fracture of hip) in Zanjan
province of Iran. Eligible patients were recruited consecutively and
interviewed by trained interviewers, using a structured questionnaire. Blood
samples were taken within 48 hours of the fracture and the 25-OHD level was
measured. Results:
Vitamin D deficiency (< 50 nmol/L) was observed in 47.7% of
patients in the case group and 43.3% of women in the control group. There was
no significant difference in mean 25-OHD levels and the rate of 25-OHD
deficiency between the two groups. Conclusion: Vitamin D deficiency was not more prevalent among postmenopausal
women with low trauma hip fracture. The present study does not support the
role of vitamin D in fragility of the hip. |
Keywords: Vitamin D deficiency, Hip fractures, Postmenopausal
Vitamin
D is an essential factor associated with chronic health conditions, including bone
health [1]. It is mainly obtained from exposure to sunlight, food and dietary
supplements [2]. In conjunction with parathyroid hormone, Vitamin D serves to
ensure sufficient serum calcium and phosphorus to promote optimal mineralization
of the skeleton [1, 3]. Vitamin D deficiency is a common problem in both developed and
developing countries, including Iran [2, 4-8]. In a vitamin D deficiency condition bone tissue doesn’t sufficiently
mineralize and secondary hyperparathyroidism leads *to bone resorption [3], both of which result in decreased bone strength and increased
risk of the fracture [2]. It has also been found that vitamin D deficient adults are at
increased risk of falling; this is reported to be a direct result of muscle weakness caused by vitamin D deficiency
[3]. Additionally, vitamin D deficiency has been found to be associated
with osteoporotic fractures such as hip fractures in older adults; this has
been reported to be particularly prevalent in post menopausal women [9-12].
Osteoporosis
is a serious health problem in elderly people, in particular postmenopausal
women. It is important to know whether vitamin D deficiency predicts higher
rates of low trauma fractures in postmenopausal women in comparison with that
among women with fractures due to high energy trauma. There has been strong
evidence, mostly from the developed world, reporting that vitamin D deficiency
is associated with osteoporotic hip fracture in the elderly [10, 13, 14]. For example, LeBoff et al [14] found vitamin D deficiency, defined as serum 25-OHD lower than 12
ng/mL, in more than half of women with osteoporotic hip fractures in the United
States. There is paucity of evidence regarding the association between
osteoporotic fragility and vitamin D status in developing countries. In Iran,
despite a high prevalence of vitamin D deficiency, the incidence of hip
fracture is low [15, 16].
However,
there appears to be an apparent lack of empirical evidence pertaining to
information on vitamin D levels in the Iranian women admitted with acute hip
fracture. Therefore, this study aimed to identify vitamin D status in patients
with osteoporotic hip fracture compared with patients who had suffered from
traumatic hip fracture.
This
study was carried out in Zanjan, Iran. Zanjan Province is located in the
northwest region of Iran, almost 300 km from the capital city (Tehran). Its
latitude is 36.41oN and it has a Mediterranean climate characterized
by cold snowy weather in the mountains, a moderate winter climate in the plains
and moderately warm summers. Based on the national census in 2007, the province
has a population of 964601, almost 14% of which are 50 years old or over [17].
The
present study was performed at Shafiea Hospital in Zanjan. From February to
September 2006, patients hospitalized with acute hip fracture were invited to
participate in the study. All patients were informed of the nature and objectives
of the study and written consent forms were taken from them. Patients were
included in the study if they were female with at least 50 years old, having
had amenorrhea for at least 12 months and were suffering from hip fracture
diagnosed by a specialist and confirmed by X-ray. Patients were excluded from
the study if they had a history of consumption of drugs containing vitamin D or
medications that influence its metabolism (during three recent months) or if
they had had a fracture due to metastatic cancer.
The
study participants comprised of two groups: cases and controls. Cases consisted
of 73 women who were postmenopausal and were diagnosed with a fracture of the
hip (caused by low trauma). The control group included 76 postmenopausal
patients with hip fracture due to high energy trauma. Low trauma indicates a trauma which does not seem to generate a
serious injury such as hip fracture. For example; falls from standing height or
less is considered as a low trauma. High energy traumatic fracture was defined
as fractures resulting from motor vehicle accidents and high height falls. Both
cases and controls were selected from the patients admitted to Shafiea Hospital
for hip fractures. Patients were enrolled consecutively and interviewed
in the hospital by trained interviewers, using a structured questionnaire.
Demographic
information obtained from respondents included age, marital status, employment
status, living place and time and cause of fracture. Information was also
collected on clinical and drug history, smoking, history of other fractures and
environmental factors that could contribute to hip fracture. Participants’
blood was collected during the first 48 hours of the fracture and serum was
immediately frozen and stored at -70° C until the laboratory test was conducted.
Early collection of blood is important to rule out the effect of trauma on the level
of serum 25-hydroxy vitamin D (25-OHD). Serum (25-OHD) was measured by an
enzyme linked immunosorbent assay (ELISA) using DRG Instruments GmbH kit. The intra-
and inter-assay coefficients of variation were 13.8 and 16.2 percent,
respectively. Vitamin D deficiency was defined as a 25-OHD level of less than
50 nmol/ L (20 ng per millilitre) [18, 19]. Vitamin D insufficiency was defined as a 25-OHD level between 50
and 75 nmol/L. Statistical analysis was performed using SPSS. The main
characteristics of the two groups were compared using a chi-square test. As
25-OHD was not normally distributed, the Mann-Whitney U test was employed to
analyze the difference between cases and controls. Categorical 25-OHD was
created using different quartile levels among all patients with hip fracture
and then number (and percent) of patients in each quartile was compared between
the two groups. The chi-square test was also used to examine the difference in
categorical 25-OHD between groups. Regression analysis was used to test the
association between the patient’s age and level of serum 25-OHD.
Seventy
three patients were diagnosed with low trauma hip fracture and 76 patients had
fractures due to high energy trauma. The characteristics of the patients of
both groups are shown in Table 1.
Table 1: Some characteristics of respondents
in the two groups with low traumatic and high energy traumatic fracture
Variable |
Total |
Low trauma |
High energy trauma fracture |
P value |
Age, mean (sd) |
65.8
(13.9) |
69.7 (14.1) |
62.1 (12.7) |
<.001 |
Vitamin D, Median |
59.1 |
53.2 |
65.6 |
0.29 |
Living place - Urban, N (%) - Rural, N (%) |
109 (73.0) 40 (26.9) |
44 (60.3) 29(39.7) |
65 (85.5) 11 (14.5) |
<.01 |
Previous fracture - Yes, N (%) - No, N (%) |
18 (12.1) 131 (87.9) |
14 (19.2) 59 (80.8) |
4 (5.3) 72 (94.7) |
<.01 |
Place of fracture - Indoor, N (%) - Outdoor, N (%) |
76 (51.0) 73 (49.0) |
64 (87.7) 9 (12.3) |
12 (15.8) 64 (84.2) |
<.001 |
Past medical history - Yes, N (%) - No, N (%) |
60 (40.3) 89 (59.7) |
38 (52.1) 35 (47.9) |
22 (28.9) 54 (71.1) |
<.01 |
Patients
in the fragility fracture group were older and more likely to live in rural
areas (p<0.01). Compared with the high energy traumatic fracture group, low
trauma cases reported higher rate of previous fractures, more past medical
history, and were more likely to have had their fracture occur indoors (p<0.01).
There was no statistical difference between the two groups in median of 25-OHD.
Serum concentrations of 25-OHD in both groups are shown in Figure 1.
Figure 1: Serum 25-OHD (nmol/l) in
patients with low trauma hip fracture (cases) and control subjects (p = 0.47)
In a
separate analysis the categorical difference in level of 25-OHD between cases
and controls was tested (Table 2). In general, less than half of the participants
had serum 25-OHD level < 50 nmol/L. Lowest quartile of vitamin
D level (25-OHD <20.5 nmol/L) was more prevalent in the control group
fracture (28.9% versus 20.5%),
while second quartile of vitamin D level (20.75 nmol/L < 25-OHD <59.1
nmol/L) was more frequent in the case group. We
only measured serum calcium in 6 patients with vitamin D level in toxic range
(> 374 nmol/l) after vitamin D assay; fortunately this level was normal in
all 6. However, this
analysis showed that the rate of vitamin D deficiency and insufficiency was not
significantly different between the two groups. In a separate analysis, we also
examined the association between patient’s age and serum 25-OHD. As the 25-OHD
was not normally distributed, we log transformed the data. Regression analysis
did not show a statistically significant association between age and level of
vitamin D (data are not shown).
Table
2: Quartile levels of serum 25-OHD in cases and controls
|
25-OHD (nmol/L) |
Toxic level |
||||
|
≤20.75 |
20.75-59.1 |
59.1-98.5 |
> 98.5 |
|
>374.00 |
Case, N (%) |
15(20.5) |
25
(34.2) |
16
(21.9) |
17(23.3) |
|
1
(1.4) |
Control, N (%) |
22
(28.9) |
13
(17.1) |
22
(28.9) |
19
(25) |
0.10 |
5
(6.6) |
To
the best of our knowledge, this is the first study that compares vitamin D
status among Iranian post menopausal women with low trauma high energy fracture
with that of patients with traumatic fracture. This study did not find a significant
difference in mean vitamin D levels and also rate of vitamin D deficiency
between the two groups. This is in consistent with the findings of Erem et al [20] which previously have shown that mean serum vitamin D of patients
with osteoporotic fractures was not different with that of the normal
population. Prevalence of hypovitaminosis in patients with hip fracture has
been reported between 50% to 100% in different countries [21-23]. Those studies indicated that hypovitaminosis D is more prevalent
among postmenopausal women and patients with osteoporosis (regardless of hip
fracture) [21-23].
Micronutrient
studies from Iran have shown that only 3.9% of postmenopausal osteoporotic women
living in northwest Iran receive adequate dietary vitamin D [24]. This seems plausible as the people in this region have a low
intake of fatty fish and their processed food is not fortified by vitamin D. However,
in a study of the prevalence of hypovitaminosis D in different age groups in
different urban areas of Iran, vitamin D deficiency in older age groups (over
50 years) is reported to be less than younger people [8, 25]. Hashemipour et al (2004) and Hesmhat and colleagues (2008) suggested
parenteral vitamin D intake by elderly as the major differentiating factor
between various age groups that could explain lower prevalence of vitamin D
deficiency in elderly females. Many physicians in Iran prescribe parenteral
vitamin D (containing 300,000IU vitamin D) for postmenopausal and elderly
patients, particularly those with musculoskeletal complaints in short intervals
(e.g., weekly) as a malpractice.
Maggio
et al [26] study indicated that the risk of vitamin D deficiency and its
severity increases with age especially after 70. In a separate analysis the current
data did not suggest any difference in rate of vitamin D deficiency among cases
older than 70 years (data are not shown). In addition, findings of the present
study do not agree with previous research that reported a higher rate of
vitamin D deficiency among residents of urban areas or lower socioeconomic
status [27, 28].
The present study must be
interpreted with cautious as there were important limitations to note. First,
serum PTH was not measured due to limited resources and future research may
endeavour to address this limitation as an assessment of serum PTH in relation to
vitamin D could indicate the presence of secondary hyperparathyroidism that can
lead to cortical bone loss and increase risk of fracture. Second, bone
densitometry was not measured in this study and the patients were categorised according
to the severity of trauma. This may have caused misclassification of the
patient, i.e. some of the patients categorised as control may have had osteoporosis
as well. Third, we selected the control group from hospital patients, rather than
normal population. This may have led to an absence of any significant
difference in vitamin D levels between cases and controls. However, mean and
median serum vitamin D levels in this study are higher than the
community-dwelling women studied by Hashemipour and colleagues [8]. Finally, there was no data about the duration of sun-exposure in
the participants. Although sun-exposure is considered an important factor in
vitamin D deficiency, previous study in Iran has shown that exposure to
sunlight is not associated with serum levels of vitamin D [8].
Conclusion
The
present study indicates a lower rate of vitamin D deficiency among patients
with acute hip fracture compared to similar studies. The present data do not
suggest an association between vitamin D deficiency and low trauma fracture. Despite a high prevalence of vitamin D deficiency in
the young population of Iran, minority of elderly women were detected to have lowest
quartile of vitamin D level. This may justify a low incidence
of hip fractures among post menopausal women in Iran.
Acknowledgments
The
authors would like to thank research nurse Mrs. Misaghi, for patient
recruitment and assistance in data collection and also all patients who
participated in this project. This research was supported by Zanjan University
vice-chancellor in research affairs as an approved student project.
1. Holick MF. Sunlight and vitamin D for bone health and
prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J
Clin Nutr 2004; 80(6Suppl):1678S-88S.
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3):266-81.
3. DeLuca HF. Overview of general physiologic features and functions of
vitamin D. Am J Clin Nutr 2004; 80(6 Suppl):1689S-96S.
4. Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, Bodeker RH & et.al. High prevalence of
vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain
in Turkish immigrants in Germany: identification of risk factors. Osteoporos
Int 2006; 17(8):1133-40.
5. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT & et.al.
Prevalence of Vitamin D inadequacy among postmenopausal North American women
receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90(6):3215-24.
6. Alagol F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H &
et.al. Sunlight exposure and vitamin D deficiency in Turkish women. J
Endocrinol Invest 2000; 23(3):173-7.
7. Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N.
Prevalence and significance of low 25-hydroxyvitamin D concentrations in
healthy subjects in Delhi. Am J Clin Nutr 2000; 72(2):472-5.
8. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M &
et.al. Vitamin D deficiency and causative factors in the population of Tehran.
BMC Public Health 2004; 4:38.
9. Bakhtiyarova S, Lesnyak O, Kyznesova N, Blankenstein MA, Lips P. Vitamin D
status among patients with hip fracture and elderly control subjects in
Yekaterinburg, Russia. Osteoporos Int 2006; 17(3):441-6.
10. Nuti R, Martini G, Valenti R, Gambera D, Gennari L, Salvadori S &
et.al. Vitamin D status and bone turnover in women with acute hip fracture.
Clin Orthop Relat Res 2004; (422):208-13.
11. Sakuma M, Endo N, Oinuma T, Hayami T, Endo E, Yazawa T & et.al.
Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int
2006; 17(11):1608-14.
12. Thiebaud D, Burckhardt P, Costanza M, Sloutskis D, Gilliard D, Quinodoz F
& et.al. Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk
factors in elderly women and men with hip fracture. Osteoporos Int 1997; 7(5):457-62.
13. Cumming RG, Klineberg RJ. Case-control study of risk factors for hip
fractures in the elderly. Am J Epidemiol 1994; 139(5):493-503.
14. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
JAMA 1999; 281(16):1505-11.
15. Moayyeri A, Soltani A, Larijani B, Naghavi M, Alaeddini F, Abolhassani F.
Epidemiology of hip fracture in Iran: results from the Iranian Multicenter
Study on Accidental Injuries. Osteoporos Int 2006; 17(8):1252-7.
16. Valizadeh M, Mazloomzadeh S, Azizi R. Epidemiology of hip fracture in
Zanjan, Iran. Arch Osteoporos 2008; 3:1-5.
17. General population and housing census in Iran. 2007. Statistical Center of
Iran . Available at: URL: http://www.Amar.org.ir/. Accessed 2007.
18. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency.
Lancet 1998; 351(9105):805-6.
19. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes
B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for
multiple health outcomes. Am J Clin Nutr 2006; 84(1):18-28.
20. Erem C, Tanakol R, Alagol F, Omer B, Cetin O. Relationship of bone
turnover parameters, endogenous hormones and vit D deficiency to hip fracture
in elderly postmenopausal women. Int J Clin Pract 2002; 56(5):333-7.
21. Beringer T, Heyburn G, Finch M, McNally C, McQuilken M, Duncan M &
et.al. Prevalence of vitamin D inadequacy in Belfast following fragility
fracture. Curr Med Res Opin 2006; 22(1):101-5.
22. Brown IR, Bakowska A, Millard PH. Vitamin D status of patients with
femoral neck fractures. Age Ageing 1976; 5(3):127-31.
23. Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS. Vitamin D
inadequacy among post-menopausal women: a systematic review. QJM 2005; 98(9):667-76.
24. Hejazi J, Mohtadinia J, Kolahi S, Ebrahimi-Mamaghani M. Nutritional status
among postmenopausal osteoporotic women in North West of Iran. Asia Pac J Clin
Nutr 2009; 18(1):48-53.
25. Heshmat R, Mohammad K, Majdzadeh SR, Forouzanfar MH, Bahrami A, Ranjbar GH
& et.al. Vitamin D deficiency in Iran: A multi-center study among different
urban areas. Iranian J Publ Health 2008; A supplementary issue on Osteoporosis
and Bone Turnover(1):72-8.
26. Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Pierandrei M
& et.al. 25(OH)D Serum levels decline with age earlier in women than in men
and less efficiently prevent compensatory hyperparathyroidism in older adults.
J Gerontol A Biol Sci Med Sci 2005; 60(11):1414-9.
27. Islam MZ, Lamberg-Allardt C, Karkkainen M, Outila T, Salamatullah Q,
Shamim AA. Vitamin D deficiency: a concern in premenopausal Bangladeshi women
of two socio-economic groups in rural and urban region. Eur J Clin Nutr 2002; 56(1):51-6.
28. Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D
deficiency and treatment with vitamin D and analogues in the prevention of
osteoporosis-related fractures. Eur J Clin Invest 1996; 26(6):436-42.
* Corresponding author: Majid Valizadeh, Metabolic
Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
E-mail: mvalizadeh47@yahoo.com